Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway

Psychoneuroendocrinology

Volumn 67, Issue , 2016, Pages 70-75

  Garcia Rizo, Clemente ^a,b,c   Kirkpatrick, Brian ^d   Fernandez Egea, Emilio ^c,e,f   Oliveira, Cristina ^a   Bernardo, Miquel ^a,b,c,g  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Major depressive disorder; Mortality; Schizophrenia; Thrifty psychiatric phenotype; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADJUSTMENT DISORDER; ADULT; ARTICLE; BIPOLAR DISORDER; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHIZOPHRENIA; BLOOD; CASE CONTROL STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; YOUNG ADULT;

ADJUSTMENT DISORDERS; ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; MALE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84962546819     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2016.02.001     Document Type: Article

References (58)

1. Allison D.B., Casey D.E. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatry 2001, 62(Suppl. 7):22-31.
2. Altamura A.C., Buoli M., Pozzoli S. Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia. Psychiatry Clin. Neurosci. 2013, 10.1111/pcn.12089.
3. Boyle M.H., Miskovic V., Van Lieshout R., Duncan L., Schmidt L.A., Hoult L., Paneth N., Saigal S. Psychopathology in young adults born at extremely low birth weight. Psychol. Med. 2011, 41:1763-1774. 10.1017/S0033291710002357.
4. Brown A.S., Susser E.S., Lin S.P., Neugebauer R., Gorman J.M. Increased risk of affective disorders in males after second trimester prenatal exposure to the Dutch hunger winter of 1944-45. Br. J. Psychiatry 1995, 166:601-606.
5. Brown S., Birtwistle J., Roe L., Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 1999, 29:697-701.
6. Calkin C., Gardner V., Ransom D.M., Alda T.M. The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann. Med. 2013, 45:171-181. 10.3109/07853890.2012.687835.
7. Carvalho L.A., Urbanova L., Hamer M., Hackett R.A., Lazzarino A.I., Steptoe A. Blunted glucocorticoid and mineralocorticoid sensitivity to stress in people with diabetes. Psychoneuroendocrinology 2015, 51:209-218. 10.1016/j.psyneuen.2014.09.023.
8. Charatan F.B.E., Bartlett N.G. The effect of chlorpromazine (largactil) on glucose tolerance. Br. J. Psychiatry 1955, 101:351-353. 10.1192/bjp.101.423.351.
9. Druss B.G., Zhao L., Von Esenwein S., Morrato E.H., Marcus S.C. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med. Care 2011, 49:599-604. [pii]. 10.1097/MLR.0b013e31820bf86e00005650-201106000-00011.
10. Eaton W.W., Martins S.S., Nestadt G., Bienvenu O.J., Clarke D., Alexandre P. The burden of mental disorders. Epidemiol. Rev. 2008, 30:1-14. [pii]. 10.1093/epirev/mxn011mxn011.
11. Edmondson D., Kronish I.M., Shaffer J.A., Falzon L., Burg M.M. Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic review. Am. Heart J. 2013, 166:806-814. [pii]. 10.1016/j.ahj.2013.07.031S0002-8703(13) 00533-4.
12. Fernandez-Egea E., Bernardo M., Donner T., Conget I., Parellada E., Justicia A., Esmatjes E., Garcia-Rizo C., Kirkpatrick B. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br. J. Psychiatry 2009, 194:434-438. 10.1192/bjp.bp.108.052605.
13. Fernandez-Egea E., Bernardo M., Donner T., Conget I., Parellada E., Justicia A., Esmatjes E., Garcia-Rizo C., Kirkpatrick B. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br. J. Psychiatry 2009, 194:434-438. 10.1192/bjp.bp.108.052605.
14. Fernandez-Egea E., Garcia-Rizo C., Zimbron J., Kirkpatrick B. Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary view. Schizophr. Bull. 2013, 39:266-267. [pii]. 10.1093/schbul/sbs134sbs134.
15. Fernandez-Egea E., Miller B., Bernardo M., Donner T., Kirkpatrick B. Parental history of type 2 diabetes in patients with nonaffective psychosis. Schizophr. Res. 2008, 98:302-306. S0920-9964(07) 00455-0[pii]. 10.1016/j.schres.2007.10.002.
16. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I disorders (SCIDI) Clinical Version, Masson, Barcelona, Spain, 1997. Spanish adaptation by Blanch and Andreu 1999.
17. Folsom D.P., Hawthorne W., Lindamer L., Gilmer T., Bailey A., Golshan S., Garcia P., Unützer J., Hough R., Jeste D.V. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am. J. Psychiatry 2005, 162:370-376. 10.1176/appi.ajp.162.2.370.
18. Garcia-Rizo C., Fernandez-Egea E., Miller B.J., Oliveira C., Justicia A., Griffith J.K., Heaphy C.M., Bernado M., Kirkpatrick B. Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain. Behav. Immun. 2012, 5-9. 10.1016/j.bbi.2012.11.009.
19. Garcia-Rizo C., Fernandez-Egea E., Miller B.J., Oliveira C., Justicia A., Griffith J.K., Heaphy C.M., Bernardo M., Kirkpatrick B. Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naïve patients with depression. Brain. Behav. Immun. 2013, 28:49-53. 10.1016/j.bbi.2012.11.009.
20. Garcia-Rizo C., Fernandez-Egea E., Bernardo M., Kirkpatrick B. The thrifty psychiatric phenotype. Acta Psychiatr. Scand. 2014, 10.1111/acps.12309.
21. Garcia-Rizo C., Kirkpatrick B., Fernandez-Egea E., Oliveira C., Meseguer A., Grande I., Undurraga J., Vieta E., Bernardo M. Is bipolar disorder an endocrine condition? Glucose abnormalities in bipolar disorder. Acta Psychiatr. Scand. 2014, 10.1111/acps.12194.
22. Gluckman P.D., Hanson M.A. Developmental Origins of Health and Disease 2006, Cambridge University Press, New York.
23. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 2008, 359:61-73. [pii]. 10.1056/NEJMra0708473359/1/61.
24. Gomez-Duran E.L., Forti-Buratti M.A., Gutierrez-Lopez B., Belmonte-Ibanez A., Martin-Fumado C. Psychiatric disorders in cases of completed suicide in a hospital area in Spain between 2007 and 2010. Rev. Psiquiatr. Salud. Ment. 2014, 14:S1888-9891. 00038-X[pii]. 10.1016/j.rpsm.2014.02.001.
25. Grande I., Magalhaes P.V., Kunz M., Vieta E., Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol. Behav. 2012, 106:46-50. [pii]. 10.1016/j.physbeh.2011.10.029S0031-9384(11) 00517-8.
26. Hales C.N., Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
27. Harley M., Kelleher I., Clarke M., Lynch F., Arseneault L., Connor D., Fitzpatrick C., Cannon M. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol. Med. 2010, 40:1627-1634. [pii]. 10.1017/S0033291709991966S0033291709991966.
28. Herva A., Räsänen P., Miettunen J., Timonen M., Läksy K., Veijola J., Laitinen J., Ruokonen A., Joukamaa M. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort study. Psychosom. Med. 2006, 68:213-216. 10.1097/01.psy.0000203172.02305.ea.
29. Hildrum B., Mykletun A., Midthjell K., Ismail K., Dahl A.A. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr. Scand. 2009, 120:14-22. 10.1111/j.1600-0447.2008.01315.x.
30. Kato K., Otsuka T., Kobayashi N., Kon Y., Kawada T. Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Diabetes Med. 2014, 31:76-83. 10.1111/dme.12288.
31. Kempf K., Rathmann W., Herder C. Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab. Res. Rev. 2008, 24:427-437. 10.1002/dmrr.869.
32. Kirkpatrick B., Messias E., Harvey P.D., Fernandez-Egea E., Bowie C.R. Is schizophrenia a syndrome of accelerated aging?. Schizophr. Bull. 2008, 34:1024-1032. sbm140[pii]. 10.1093/schbul/sbm140.
33. Kirkpatrick B., Miller B.J., Garcia-Rizo C., Fernandez-Egea E., Bernardo M. Is abnormal glucose tolerance in antipsychotic-na? ve patients with nonaffective psychosis confounded by poor health habits?. Schizophr. Bull. 2012, 38:280-284. 10.1093/schbul/sbq058.
34. Ko C.-Y., Liu Y.-P. Isolation rearing impaired sensorimotor gating but increased pro-inflammatory cytokines and disrupted metabolic parameters in both sexes of rats. Psychoneuroendocrinology 2015, 55:173-183. 10.1016/j.psyneuen.2015.02.007.
35. Laursen T.M., Munk-Olsen T., Nordentoft M., Mortensen P.B. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J. Clin. Psychiatry 2007, 68:899-907.
36. Laursen T.M., Nordentoft M., Mortensen P.B. Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 2013, 10:425-448. 10.1146/annurev-clinpsy-032813-153657.
37. Leigh H. A proposal for a new multiaxial model of psychiatric diagnosis. A continuum-based patient model derived from evolutionary developmental gene-environment interaction. Psychopathology 2009, 42:1-10. [pii]. 10.1159/000173698000173698.
38. Maudsley H. The pathology of mind: Being the of the second part of the "Physiology and pathology of mind," recast, enlarged, and rewritten 1880, Appleton, New York. 3rd ed.
39. McIntyre R.S., Mancini D.A., Pearce M.M., Silverstone P., Chue P., Misener V.L., Konarski J.Z. Mood and psychotic disorders and type 2 diabetes: a metabolic triad. Can. J. Diabetes 2005, 29:122-132.
40. Meyer C., Pimenta W., Woerle H.J., Van Haeften T., Szoke E., Mitrakou A., Gerich J. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006, 29:1909-1914. 29/8/1909[pii]. 10.2337/dc06-0438.
41. Miller-Archie S.A., Jordan H.T., Ruff R.R., Chamany S., Cone J.E., Brackbill R.M., Kong J., Ortega F., Stellman S.D. Posttraumatic stress disorder and new-onset diabetes among adult survivors of the World Trade Center disaster. Prev. Med. 2014, 66C:34-38. S0091-7435(14) 00182-0[pii]. 10.1016/j.ypmed.2014.05.016.
42. Mitchell A.J., Vancampfort D., De Herdt A., Yu W., De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr. Bull. 2013, 39:295-305. [pii]. 10.1093/schbul/sbs082sbs082.
43. Ning F., Zhang L., Dekker J.M., Onat A., Stehouwer C.D., Yudkin J.S., Laatikainen T., Tuomilehto J., Pyorala K., Qiao Q. Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc. Diabetol. 2012, 11:76. 1475-2840-11-76 [pii]. 10.1186/1475-2840-11-76.
44. Nordentoft M., Wahlbeck K., Hallgren J., Westman J., Osby U., Alinaghizadeh H., Gissler M., Laursen T.M. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 2013, 8:e55176. [pii]. 10.1371/journal.pone.0055176PONE-D-12-26455.
45. Nugent K.L., Chiappelli J., Rowland L.M., Hong L.E. Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load. Psychoneuroendocrinology 2015, 60:120-129. 10.1016/j.psyneuen.2015.06.009.
46. Pacheco-Lopez G., Giovanoli S., Langhans W., Meyer U. Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophr. Bull. 2011, 39:319-329. sbr178[pii]. 10.1093/schbul/sbr178.
47. Reynolds R.M., Labad J., Buss C., Ghaemmaghami P., Räikkönen K. Transmitting biological effects of stress in utero: implications for mother and offspring. Psychoneuroendocrinology 2013, 38:1843-1849. 10.1016/j.psyneuen.2013.05.018.
48. Rizzo L.B., Costa L.G., Mansur R.B., Swardfager W., Belangero S.I., Grassi-Oliveira R., McIntyre R.S., Bauer M.E., Brietzke E. The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research. Neurosci. Biobehav. Rev. 2014, 14:S0149-7634. 00024-4[pii]. 10.1016/j.neubiorev.2014.02.004.
49. Roy T., Lloyd C.E. Epidemiology of depression and diabetes: a systematic review. J. Affect Disord. 2012, (Suppl. 142):S8-21. [pii]. 10.1016/S0165-0327(12) 70004-6S0165-0327(12) 70004-6.
50. Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 2003, 160:284-289.
51. Saddichha S., Manjunatha N., Ameen S., Akhtar S. Diabetes and schizophrenia-effect of disease or drug. Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatr. Scand. 2008, 117:342-347. 10.1111/j.1600-0447.2008.01158.x.
52. Salvatore P., Baldessarini R.J., Tohen M., Khalsa H.M., Sanchez-Toledo J.P., Zarate C.A., Vieta E., Maggini C. McLean-Harvard international first-episode project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J. Clin. Psychiatry 2009, 70:458-466. ej08m04227 [pii].
53. Spelman L.M., Walsh P.I., Sharifi N., Collins P., Thakore J.H. Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia. Diabetes Med. 2007, 24:481-485. DME2092[pii]. 10.1111/j.1464-5491.2007.02092.x.
54. Susser E., St Clair D. Prenatal famine and adult mental illness: interpreting concordant and discordant results from the Dutch and Chinese famines. Soc. Sci. Med. 2013, 13:S0277-9536. 00152-4[pii]. 10.1016/j.socscimed.2013.02.049.
55. Whincup P.H., Kaye S.J., Owen C.G., Huxley R., Cook D.G., Anazawa S., Barrett-Connor E., Bhargava S.K., Birgisdottir B.E., Carlsson S., de Rooij S.R., Dyck R.F., Eriksson J.G., Falkner B., Fall C., Forsén T., Grill V., Gudnason V., Hulman S., Hyppönen E., Jeffreys M., Lawlor D.A., Leon D.A., Minami J., Mishra G., Osmond C., Power C., Rich-Edwards J.W., Roseboom T.J., Sachdev H.S., Syddall H., Thorsdottir I., Vanhala M., Wadsworth M., Yarbrough D.E. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008, 300:2886-2897. 10.1001/jama.2008.886.
56. Wilkinson P.O., Goodyer I.M. Childhood adversity and allostatic overload of the hypothalamic-pituitary-adrenal axis: a vulnerability model for depressive disorders. Dev. Psychopathol. 2011, 23:1017-1037. [pii]. 10.1017/S0954579411000472S0954579411000472.
57. Willis T. A Medical Odyssey 1971, Tuckahoe, New York.
58. Wolkowitz O.M., Reus V.I., Mellon S.H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin. Neurosci. 2011, 13:25-39.